Belsomra (Suvorexant) Cost in Utah: Prices, Insurance, and Savings in 2026

What Belsomra Actually Costs at Utah Pharmacies

The gap between the sticker price and what Utah residents pay out of pocket is wide. Merck's wholesale acquisition cost (WAC) sits at $340 per month for a 30-tablet supply, but that figure rarely reflects the price a patient sees at the register.

Retail Cash Prices Across Utah

Across independent pharmacies and major chains in Salt Lake City, Provo, Ogden, and St. George, the average cash-pay price for Belsomra in 2026 lands near $85 per month. Prices can swing by $20 to $40 depending on the pharmacy. Costco and Walmart locations in the Wasatch Front corridor tend to cluster at the lower end of that range, while smaller rural pharmacies sometimes charge closer to $110.

Why the List Price Rarely Applies

Pharmacy benefit managers negotiate rebates with Merck that reduce the effective cost well below $340. Even uninsured patients can access discount pricing through GoodRx-type coupon aggregators or Merck's own savings program. The $340 figure matters mainly for patients with high-deductible plans who pay a percentage of WAC before their deductible is met.

How Belsomra Compares to Other Sleep Medications

For context, generic zolpidem (Ambien) runs $8 to $15 per month at most Utah pharmacies. Generic eszopiclone (Lunesta) costs $15 to $30. Belsomra's premium reflects both its patent-protected status and its distinct mechanism as a dual orexin receptor antagonist, which blocks wake-promoting neuropeptides rather than broadly sedating the central nervous system [1]. Whether that pharmacologic distinction justifies the price difference depends on the clinical scenario, specifically whether a patient has failed or cannot tolerate older hypnotics.

Utah Medicaid and Belsomra Coverage

Utah Medicaid does not cover Belsomra on its preferred drug list as of 2026. This affects roughly 420,000 Utahns enrolled in traditional Medicaid and the Medicaid expansion population.

What "Not Covered" Means in Practice

When a drug falls off Utah Medicaid's PDL, it does not necessarily mean zero access. Prescribers can submit a prior authorization (PA) request documenting that the patient has tried and failed formulary-preferred alternatives. Utah Medicaid typically requires documented trials of at least two preferred agents, which usually includes generic zolpidem and trazodone, before considering a non-preferred brand like Belsomra.

Approval Rates for Non-Preferred Sleep Drugs

PA approval for non-formulary insomnia medications in state Medicaid programs hovers around 30% to 45% nationally, according to data reviewed by the American Academy of Sleep Medicine [2]. Utah does not publish drug-specific PA approval rates, but providers who document two failed formulary trials with specific adverse effects (next-day sedation, parasomnias, tolerance) report higher success rates than those submitting bare-minimum paperwork.

Medicaid Managed Care Plans

Most Utah Medicaid beneficiaries are enrolled in a managed care organization (MCO). Each MCO maintains its own formulary, and coverage decisions for Belsomra may differ from fee-for-service Medicaid. Check your MCO's formulary directly or call the member services number on your card before assuming the drug is excluded.

Insurance Coverage for Belsomra in Utah

Commercial insurance plans in Utah handle Belsomra inconsistently. Tier placement, co-pay amounts, and PA requirements vary by carrier and plan design.

Common Tier Placements

Most Utah commercial plans that cover Belsomra place it on Tier 3 (preferred brand) or Tier 4 (non-preferred brand). A Tier 3 co-pay typically runs $40 to $75 per month. Tier 4 co-pays or coinsurance can reach $80 to $150, especially on plans from SelectHealth, Regence, or DMBA.

Plans That Commonly Cover Belsomra

SelectHealth (Intermountain's affiliated plan), PEHP (Public Employees Health Program), and several University of Utah employee plans have historically included Belsomra on formulary with step therapy requirements. Step therapy means the insurer requires a trial of a cheaper alternative first, a process similar to Medicaid's PA pathway.

Self-Funded Employer Plans

Large Utah employers like Intermountain Health, Zions Bancorporation, and the LDS Church operate self-funded plans that may set their own formulary rules independent of state insurance mandates. If you work for a large employer, the plan's pharmacy benefit manager (Express Scripts, CVS Caremark, or Optum Rx) controls formulary decisions. Call the PBM directly for the most accurate coverage answer.

TRICARE and VA

Active-duty military and veterans along the Wasatch Front (Hill Air Force Base, Camp Williams, VA Salt Lake City Health Care System) can access Belsomra through TRICARE and VA formularies, though both require PA documentation. The VA national formulary lists suvorexant as non-formulary, requiring a non-formulary request from the prescribing provider. Co-pays through the VA are typically $11 for a 30-day supply of a non-formulary brand [3].

The Merck Savings Card and Other Discount Programs

Merck operates a co-pay assistance program for commercially insured patients that can reduce out-of-pocket costs to as low as $0 to $30 per month, depending on plan design [4].

Who Qualifies for the Merck Card

The savings card is available to patients with commercial insurance. It does not apply to prescriptions paid by Medicare, Medicaid, TRICARE, or any other federal or state government program. Patients must have a valid prescription, and the card typically caps annual savings at $3,400.

How to Activate It

Patients can enroll online at Merck's product site or receive a card through their prescriber's office. The card functions as a secondary co-pay coupon at the pharmacy counter. Processing takes one to two minutes at pickup.

GoodRx and RxSaver Coupons

For uninsured Utah patients, pharmacy discount aggregators can reduce the cash price below the $85 average. Prices fluctuate weekly, so checking multiple platforms at the time of fill gives the best result. These coupons are not insurance and cannot be combined with insurance co-pays.

Manufacturer Patient Assistance (Merck Helps)

Uninsured patients with household income below 400% of the federal poverty level ($62,400 for an individual in 2026) may qualify for Merck's patient assistance program, which provides Belsomra at no cost. Applications require income verification and a prescriber signature. Approval typically takes two to four weeks.

Compounded Suvorexant in Utah

Compounded suvorexant is available through licensed 503A compounding pharmacies in Utah. This option exists because compounding pharmacies can legally prepare formulations of FDA-approved drugs when they meet specific patient-prescriber requirements.

Legal Framework

Under federal law (FDCA Section 503A) and Utah's pharmacy practice act, a 503A pharmacy can compound suvorexant from bulk active pharmaceutical ingredient (API) when a prescriber writes a patient-specific prescription [5]. The compound must not be "essentially a copy" of the commercially available product, so compounders typically prepare suvorexant in a different dosage form (capsule instead of tablet) or in a non-commercially available strength.

Cost of Compounded Suvorexant

Pricing at Utah compounding pharmacies varies widely. Some 503A pharmacies offer compounded suvorexant capsules for significantly less than brand Belsomra, while others price closer to the retail cash-pay range. Request quotes from at least two compounders. Utah-based compounding pharmacies with 503A licenses include locations in Salt Lake City, Orem, and Logan.

Quality Considerations

Compounded medications are not FDA-approved finished products. They do not undergo the same batch testing, stability studies, or bioequivalence testing as manufactured drugs. The FDA's compounding guidance recommends that patients and prescribers weigh the clinical need for compounding against the quality assurance differences [5]. For a drug like suvorexant, where precise dosing affects both efficacy and next-day impairment risk, this tradeoff deserves a direct conversation with the prescribing clinician.

Telehealth Prescribing of Belsomra in Utah

Utah permits telehealth prescribing of Belsomra without geographic restriction within the state. A prescriber licensed in Utah can evaluate a patient via synchronous audio-video visit and issue a suvorexant prescription to any Utah pharmacy.

DEA Scheduling and Telehealth Rules

Suvorexant is a Schedule IV controlled substance under the DEA's classification [6]. Under the Controlled Substances Act and Utah's prescribing rules, Schedule IV medications can be prescribed via telehealth as long as the prescriber conducts an adequate medical evaluation. An initial video visit establishing the diagnosis and treatment rationale meets this standard.

Which Telehealth Platforms Prescribe Belsomra

National telehealth platforms (Cerebral, Done, Brightside) and Utah-based services can prescribe Belsomra if their formularies include it. Not all platforms stock or prescribe brand-name sleep medications, so confirm availability before booking.

Telehealth and Insurance

Insurance coverage for the telehealth visit itself is separate from drug coverage. Most Utah commercial plans cover telehealth visits with the same co-pay as an in-office visit, per Utah's telehealth parity law (Utah Code 31A-22-649). The prescription, once written, processes through the patient's pharmacy benefit regardless of whether the visit was virtual.

Clinical Context: Is Belsomra Worth the Cost?

Price matters, but so does whether the drug works. Suvorexant's efficacy data comes primarily from two Phase III trials.

The Herring et al. Trial

In the key 2014 trial published in The Lancet Neurology (N=3,291), suvorexant improved subjective sleep onset by a mean of 8 to 12 minutes versus placebo over 3 months, with sustained efficacy at 12 months [1]. Wake after sleep onset (WASO) decreased by approximately 16 to 23 minutes compared to placebo. These effects are statistically significant but clinically modest. The FDA's medical review acknowledged this, noting that the recommended starting dose was lowered from 30/40 mg to 10/20 mg due to next-day driving impairment at higher doses [4].

Who Benefits Most

The American Academy of Sleep Medicine's 2017 clinical practice guideline recommends suvorexant as a treatment option for sleep maintenance insomnia, giving it a "WEAK" recommendation based on moderate-quality evidence [2]. Patients most likely to benefit include those with sleep maintenance difficulty (waking during the night) who have not responded to cognitive behavioral therapy for insomnia (CBT-I), which remains the first-line treatment per AASM guidelines [7].

Dr. Andrew Krystal, a sleep medicine researcher at UCSF, has stated: "Orexin antagonists represent a mechanistically distinct approach that avoids some of the tolerability concerns of older hypnotics, particularly the abuse liability and rebound insomnia seen with benzodiazepine receptor agonists" [1].

Side Effect Profile

The most common adverse effects in trials were somnolence (7% vs. 3% placebo), headache, and dizziness. Suvorexant carries a lower abuse potential than zolpidem based on human abuse potential studies submitted to the FDA, though it remains Schedule IV. The FDA label warns against use with other CNS depressants and in patients with narcolepsy [4].

The AASM guideline panel noted: "The relatively novel mechanism of orexin receptor antagonism provides an alternative for patients who experience paradoxical reactions or complex sleep behaviors with GABA-A receptor agonists" [7].

How to Get the Lowest Price on Belsomra in Utah

A step-by-step approach to minimizing cost:

Step 1: Check Your Formulary

Log in to your insurer's member portal or call the number on your pharmacy card. Ask specifically: "Is suvorexant (Belsomra) on my formulary, and what tier?" If it requires step therapy, ask what drugs you need to try first.

Step 2: Ask About the Merck Savings Card

If you have commercial insurance and Belsomra is covered (even at Tier 4), the Merck co-pay card can reduce your co-pay to $30 or less. This single step often makes the biggest cost difference.

Step 3: Compare Cash Prices

If you are uninsured or your plan excludes Belsomra entirely, compare cash prices at five or more Utah pharmacies. Costco does not require a membership for pharmacy purchases. Independent pharmacies sometimes match or beat chain prices if asked.

Step 4: Explore Compounding

If brand Belsomra exceeds your budget, ask your prescriber about compounded suvorexant from a Utah 503A pharmacy. Discuss the quality tradeoffs described above.

Step 5: Apply for Patient Assistance

If your income qualifies, Merck's patient assistance program provides Belsomra at no cost. This is the lowest-price option for eligible patients but takes several weeks to process.

Step 6: Reassess the Clinical Need

If cost remains a barrier after exploring all options, revisit the treatment plan with your prescriber. Generic alternatives like zolpidem ($8 to $15/month), suvorexant's DORA-class competitor lemborexant (Dayvigo), or non-pharmacologic treatment with CBT-I may be appropriate depending on your insomnia subtype and prior treatment history. CBT-I, delivered in person or via digital platforms like Somryst, produces durable improvements in chronic insomnia without ongoing medication cost [8].